Short Interest in IM Cannabis Corp. (NASDAQ:IMCC) Decreases By 38.0%

IM Cannabis Corp. (NASDAQ:IMCC) was the target of a significant decline in short interest in February. As of February 13th, there was short interest totaling 19,228 shares, a decline of 38.0% from the January 29th total of 30,993 shares. Based on an average daily volume of 38,381 shares, the short-interest ratio is presently 0.5 days. Approximately 0.3% of the shares of the company are sold short. Approximately 0.3% of the shares of the company are sold short. Based on an average daily volume of 38,381 shares, the short-interest ratio is presently 0.5 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of IM Cannabis in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, IM Cannabis presently has an average rating of “Sell”.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Hidden Cove Wealth Management LLC purchased a new position in IM Cannabis during the third quarter worth $27,000. DRW Securities LLC acquired a new stake in shares of IM Cannabis during the fourth quarter valued at $32,000. Heron Bay Capital Management purchased a new stake in IM Cannabis during the 2nd quarter worth about $195,000. Finally, Yorkville Advisors Global LP acquired a new position in IM Cannabis in the 3rd quarter valued at about $1,452,000. 7.68% of the stock is currently owned by institutional investors and hedge funds.

IM Cannabis Price Performance

NASDAQ:IMCC traded down $0.04 during trading hours on Friday, hitting $0.68. The company’s stock had a trading volume of 41,647 shares, compared to its average volume of 57,949. IM Cannabis has a 52-week low of $0.68 and a 52-week high of $7.12. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.56 and a current ratio of 0.82. The business’s 50-day moving average is $1.26 and its two-hundred day moving average is $1.63. The company has a market capitalization of $4.01 million, a PE ratio of -0.87 and a beta of 2.10.

About IM Cannabis

IM Cannabis Corp is a vertically integrated medical cannabis company based in Israel, specializing in the research, cultivation and production of cannabis-based formulations. The company holds three key licenses granted by the Israeli Ministry of Health, covering cultivation, possession and distribution of medical-grade cannabis. Its production facilities in Moshav Yizrael feature controlled-environment agriculture chambers designed to deliver consistent, high-purity cannabinoid profiles.

The company’s product portfolio includes standardized cannabis oils, distillates, vaporizer cartridges and topical preparations, all formulated under Good Manufacturing Practice (GMP) standards.